Status:
NOT_YET_RECRUITING
Intestinal Microbiota and Visceral Pain in Chronic Intestinal Pseudo-Obstruction Syndrome (CIPO)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Intestinal Obstruction
Eligibility:
All Genders
1-21 years
Brief Summary
Chronic Intestinal Pseudo-Obstruction Syndrome (CIPO) is a rare gastrointestinal motility disorder. CIPO evolves through iterative flare-ups that can be triggered by viral or bacterial infections, psy...
Detailed Description
The aim of the study is to identify metabolites differentially produced by the gut microbiota of CIPO patients with visceral pain to determine their effect on the host with a focus on intestinal homeo...
Eligibility Criteria
Inclusion
- Patient aged 1 to 21 years
- Patient diagnosed with CIPO for at least 12 months (= patients meeting at least 2 of the following 4 criteria: 1. Recurrent episodes of intestinal dilatation, 2. Inability to maintain nutrition, 3. Intestinal neuromuscular alteration and 4. Genetic variants.)
- Patient with an ileal or colonic digestive diversion
- Signature of informed consent by both holders of parental authority and agreement in principle given orally by the subject;
- Patients affiliated to a social security scheme
Exclusion
- \-
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06610929
Start Date
October 1 2024
End Date
November 1 2025
Last Update
September 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Debre Hospital
Paris, France, 75019